TRIM39 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.62089999983439E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.86330000054802E-07 |
Normal-vs-Stage2 |
1.064460E-02 |
Normal-vs-Stage3 |
9.367800E-04 |
Normal-vs-Stage4 |
1.566260E-02 |
Stage1-vs-Stage2 |
7.258200E-01 |
Stage1-vs-Stage3 |
8.791200E-01 |
Stage1-vs-Stage4 |
5.167000E-01 |
Stage2-vs-Stage3 |
6.896600E-01 |
Stage2-vs-Stage4 |
4.435200E-01 |
Stage3-vs-Stage4 |
6.293600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.67660000005965E-07 |
Normal-vs-AfricanAmerican |
2.240500E-04 |
Normal-vs-Asian |
8.783100E-04 |
Caucasian-vs-AfricanAmerican |
5.641000E-01 |
Caucasian-vs-Asian |
5.050200E-01 |
AfricanAmerican-vs-Asian |
3.643600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.02110000010924E-07 |
Normal-vs-Female |
1.402190E-03 |
Male-vs-Female |
1.701250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
7.67750000000289E-05 |
Normal-vs-Extreme_Weight |
6.40739999946405E-07 |
Normal-vs-Obese |
3.037400E-03 |
Normal-vs-Extreme_Obese |
9.86600000000282E-05 |
Normal_Weight-vs-Extreme_Weight |
9.015800E-01 |
Normal_Weight-vs-Obese |
1.152980E-01 |
Normal_Weight-vs-Extreme_Obese |
7.548800E-01 |
Extreme_Weight-vs-Obese |
7.421700E-02 |
Extreme_Weight-vs-Extreme_Obese |
6.710600E-01 |
Obese-vs-Extreme_Obese |
1.753000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.396600E-04 |
Normal-vs-Age(41-60Yrs) |
2.165600E-04 |
Normal-vs-Age(61-80Yrs) |
1.0389000004718E-07 |
Normal-vs-Age(81-100Yrs) |
1.397060E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.980200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.578200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.877600E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.694400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.368200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.025000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.011220E-04 |
Normal-VS-Type2 PRCC |
1.18720000497063E-08 |
Normal-VS-KIRP CIMP |
1.621750E-04 |
Normal-VS-Unclassified PRCC |
4.441100E-04 |
Type1 PRCC-VS-Type2 PRCC |
2.924000E-03 |
Type1 PRCC-VS-KIRP CIMP |
1.297750E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.939600E-01 |
Type2 PRCC-VS-KIRP CIMP |
8.392200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.682400E-01 |
KIRP CIMP-VS-Unclassified PRCC |
4.156400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.72619995864443E-09 |
Normal-vs-N1 |
1.546490E-02 |
Normal-vs-N2 |
9.834500E-04 |
N0-vs-N1 |
1.150040E-01 |
N0-vs-N2 |
5.422000E-01 |
N1-vs-N2 |
2.717600E-01 |
|
|